ABSTRACT
Cardiogenic shock (CS) is the most common cause of death among inpatients with acute myocardial infarction. Although high, mortality rates are declining, and this is thought to be a result of increasing utilisation of re-perfusion therapy, revascularisation, and haemodynamic support with intra-aortic balloon pumping (IABP).
